It has been found vastly effective against airborne novel Coronavirus. The advanced study was conducted at the Columbia University Irving Medical Center, a world-renowned research institute in the United States.
In this study, a highly concentrated solution of the Omicron BA.1 variant, a mutated strain of the novel coronavirus (SARS-CoV-2), was sprayed into a 102L test box in the form of an aerosol followed by releasing Plasmacluster ions (ion density approximately 25,000 pcs/cm3) to verify the effectiveness of reducing airborne virus. The results showed a drastic reduction of the virus infectious titer (99.3% reduction after 15 minutes of exposure), indicating that Plasmacluster technology is vastly effective against mutated and highly infectious airborne Omicron variants. Sharp’s proprietary air purification technology has 100 million products categories, equipped with Plasmacluster ion technology, including air purifiers, air conditioners, refrigerators, and additional product categories.
Narita Osamu, MD, SHARP Ltd & Professor Moriya Tsuji, Columbia University Irving Medical Center said, “With the growing numbers of mutations of novel Coronavirus (SARS-CoV-2) that have surfaced over the past two years, we believe a new direction to address the human safety concerns, strong belief application of this Plasmacluster technology as a counter measure against respiratory virus infections should hold great promise to our society in the future.”
